Lattice Biologics (Lattice Biologics) Liabilities-to-Assets : 0.84 (As of Jun. 2021)

Lattice Biologics Liabilities-to-Assets Chart

Lattice Biologics Annual Data
	Trend	Dec10	Dec11	Dec12	Dec13	Dec14	Sep16	Sep17	Sep18	Sep19	Sep20
Liabilities-to-Assets		Get a 7-Day Free Trial					2.28	2.24	2.74	3.78	3.12

Lattice Biologics Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Liabilities-to-Assets	Get a 7-Day Free Trial															3.75	3.12	3.33	3.52	0.84

Competitive Comparison of Lattice Biologics's Liabilities-to-Assets

For the Medical Devices subindustry, Lattice Biologics's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lattice Biologics's Liabilities-to-Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Liabilities-to-Assets falls into.

Lattice Biologics Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Lattice Biologics's Liabilities-to-Assets Ratio for the fiscal year that ended in Sep. 2020 is calculated as:

Lattice Biologics's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lattice Biologics  (OTCPK:LBLTF) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Lattice Biologics Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Lattice Biologics (Lattice Biologics) Business Description